Description: This session discusses the key issues in the Medicare reform debate and the direction of future change. Topics include Medicare + Choice and the employer perspective. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 5pd.

Description: This 1993 paper examined the premium rate changes that could have resulted from the passage of The Health Insurance Reform and Cost Control Act of 1991. From Actuarial Research Clearing House 1993, VOL. 3.

Description: Letters to the editor of In The Public Interest discussing social insurance articles from the previous issue.

Description: This article provides comments from leading health actuaries on Clinton's health care proposal.

Description: This presentation from Session 78PD of the SOA 1999 San Francisco Annual Meeting discusses state health-care reform over the past decade and offers insights as to what has worked, what hasn't, and what has been a total disaster. The panelists further discuss the states' responses to reforms that simply have not worked and the industry's response to this challenging environment. Finally, they share their ideas of the direction they expect to see state-level reforms to take. From the Record of the Society of Actuaries, Vol. 25, No. 3.

Description: Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can help to shape our expectations of the financial impact that could result from this year’s big event. Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can help to shape our expectations of the financial impact that could result from this year’s big event.

Description: This session will review the challenges the Affordable Care Act has faced since its enactment in 2010 and will look forward to where it’s headed in the future. Panelists will discuss current ACA legislative and regulatory activities as well as ongoing ACA litigation.

Description: US pharmacy prices have entered a new era of growth driven by Specialty medications. A bevy of state and national regulations have been proposed to address pharmacy pricing, industry structure and transparency.Health actuaries will learn about US pharmacy pricing structure and how proposed legislation could affect future costs. Actuaries that have responsibility for pharmacy rate/budget setting, RFPs or trend projection will benefit from a deeper understanding of the US pharmacy market landscape and gain an international perspective.

Description: Discusses Notice 2011-02 as it addresses most, but not all, of the outstanding questions about health-care-insurance entities to which the $500,000 compensation rule applies.

Description: Panelists present the positions being staked out by the political parties, the likelihood of passage of any of the proposed legislation, and the potential impacts on the health care market of the various proposals. From the Record of the Society of Actuaries, Volume 27, No. 3, Session 131PD.